Krystal Biotech (KRYS) Stock Forecast for 2024–2028. Sell or Buy Prediction







Maximizing Profits: When is the Right Time to Sell Your Business?

April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?

Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…

Krystal Biotech (KRYS) Stock Forecast for 2024–2028. Sell or Buy?

Updated: July 27, 2024 (09:10)

Sector: Healthcare

The share price of Krystal Biotech, Inc. (KRYS) now

Latest session on the 26th of July for
Krystal Biotech, Inc. is positive
Trading Volume: 234535
Open: 213.24 /  High: 219.34 /  Low: 210.8
What analysts predict: $189
52-week High/Low: $214.98 / $93.95

50/200 Day Moving Average: $178.88 / $144.69

This figure corresponds to the Average Price over the previous 50/200 days. For Krystal Biotech stocks, the 50-day moving average is the support level today.

For Krystal Biotech stocks, the 200-day moving average is the support level today.

Are you interested in Krystal Biotech, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Krystal Biotech stock price in 2024, 2025, 2026, 2027, 2028. How much will one Krystal Biotech share be worth in 2024 - 2028?

When should I take profit in Krystal Biotech stock? When should I record a loss on Krystal Biotech stock? What are analysts' forecasts for Krystal Biotech stock? What is the future of Krystal Biotech stock? We forecast Krystal Biotech stock performance using neural networks based on historical data on Krystal Biotech stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Krystal Biotech stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Krystal Biotech shares. This happens once a day.


Historical and forecast chart of Krystal Biotech stock

The chart below shows the historical price of Krystal Biotech stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Krystal Biotech stock price can be found in the table below.

Long-term forecasts by years.

Krystal Biotech is a clinical gene therapy drug manufacturer committed to creating and marketing advanced therapies for skin patients. The company has developed and patented a gene therapy platform that enables the development of ready-to-use treatments for skin conditions that cannot be cured with known methods.

Krystal Biotech daily forecast for a month

Date Target Pes. Opt. Vol., %
Jul 29 214.82 212.67 217.31 2.18
Jul 30 215.08 211.55 218.60 3.33
Jul 31 209.83 205.21 212.93 3.76
Aug 01 208.57 203.48 210.99 3.69
Aug 02 214.74 209.07 219.38 4.93
Aug 03 215.86 209.13 218.02 4.25
Aug 04 215.43 212.15 218.36 2.92
Aug 05 214.83 210.87 221.18 4.89
Aug 06 213.02 210.55 215.83 2.51
Aug 07 215.32 213.25 220.06 3.19
Aug 08 213.69 208.90 217.96 4.34
Aug 09 216.08 209.25 221.35 5.78
Aug 10 219.02 213.15 224.89 5.51
Aug 11 215.78 211.98 218.71 3.18
Aug 12 218.36 213.91 221.25 3.43
Aug 13 224.57 218.10 227.44 4.28
Aug 14 222.05 217.61 228.09 4.82
Aug 15 227.03 222.30 232.75 4.70
Aug 16 226.48 224.58 229.02 1.98
Aug 17 220.50 214.94 223.94 4.19
Aug 18 220.06 213.55 224.64 5.19
Aug 19 222.26 220.39 227.68 3.31
Aug 20 220.04 213.53 223.65 4.74
Aug 21 223.38 217.40 230.53 6.04
Aug 22 226.69 222.97 233.85 4.88
Aug 23 225.15 221.82 231.00 4.14
Aug 24 223.89 222.01 226.66 2.10
Aug 25 217.35 213.61 220.39 3.17
Aug 26 215.52 211.90 218.11 2.93
Aug 27 209.66 205.55 216.03 5.10

Krystal Biotech Daily Price Targets


Krystal Biotech Stock Forecast 07-29-2024.

Forecast target price for 07-29-2024: $214.82.
Positive dynamics for Krystal Biotech shares will prevail with possible volatility of 2.136%.
Pessimistic target level: 212.67
Optimistic target level: 217.31

Krystal Biotech Stock Forecast 07-30-2024.

Forecast target price for 07-30-2024: $215.08.
Positive dynamics for Krystal Biotech shares will prevail with possible volatility of 3.227%.
Pessimistic target level: 211.55
Optimistic target level: 218.60

Krystal Biotech Stock Forecast 07-31-2024.

Forecast target price for 07-31-2024: $209.83.
Negative dynamics for Krystal Biotech shares will prevail with possible volatility of 3.626%.
Pessimistic target level: 205.21
Optimistic target level: 212.93

Krystal Biotech Stock Forecast 08-01-2024.

Forecast target price for 08-01-2024: $208.57.
Negative dynamics for Krystal Biotech shares will prevail with possible volatility of 3.559%.
Pessimistic target level: 203.48
Optimistic target level: 210.99

Krystal Biotech Stock Forecast 08-02-2024.

Forecast target price for 08-02-2024: $214.74.
Positive dynamics for Krystal Biotech shares will prevail with possible volatility of 4.699%.
Pessimistic target level: 209.07
Optimistic target level: 219.38

Krystal Biotech Stock Forecast 08-03-2024.

Forecast target price for 08-03-2024: $215.86.
Positive dynamics for Krystal Biotech shares will prevail with possible volatility of 4.079%.
Pessimistic target level: 209.13
Optimistic target level: 218.02

KRYS (KRYS) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Aug. 210.69 203.11 226.11 10.18
Sep. 223.33 208.86 240.22 13.05
Oct. 220.65 209.27 235.21 11.03
Nov. 224.36 212.24 231.63 8.37
Dec. 206.86 200.16 226.47 11.62

Krystal Biotech forecast for this year


Krystal Biotech Stock Prediction for Aug 2024

An downtrend is forecast for this month with an optimal target price of $210.69. Pessimistic: $203.11. Optimistic: $226.11


Krystal Biotech Stock Prediction for Sep 2024

An uptrend is forecast for this month with an optimal target price of $223.331. Pessimistic: $208.86. Optimistic: $240.22


Krystal Biotech Stock Prediction for Oct 2024

An downtrend is forecast for this month with an optimal target price of $220.651. Pessimistic: $209.27. Optimistic: $235.21


Krystal Biotech Stock Prediction for Nov 2024

An uptrend is forecast for this month with an optimal target price of $224.358. Pessimistic: $212.24. Optimistic: $231.63


Krystal Biotech Stock Prediction for Dec 2024

An downtrend is forecast for this month with an optimal target price of $206.858. Pessimistic: $200.16. Optimistic: $226.47



Krystal Biotech (KRYS) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 201.65 183.50 209.39 12.37
Feb 200.44 194.66 218.48 10.90
Mar 202.36 191.19 217.17 11.96
Apr 205.03 192.73 214.38 10.10
May 229.64 223.02 246.72 9.61
Jun 215.03 205.23 235.42 12.82
Jul 222.77 205.40 234.00 12.22
Aug 209.41 200.86 222.72 9.82
Sep 197.09 191.42 211.99 9.71
Oct 196.38 178.47 212.41 15.98
Nov 201.33 195.05 212.69 8.29
Dec 210.51 194.60 216.83 10.25

Krystal Biotech (KRYS) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 218.85 213.07 224.89 5.26
Feb 225.68 212.41 243.55 12.79
Mar 230.01 214.83 236.63 9.21
Apr 222.01 205.22 231.06 11.18
May 215.61 195.17 236.05 17.32
Jun 217.16 202.31 229.41 11.81
Jul 215.08 194.43 228.50 14.91
Aug 206.82 197.64 216.50 8.71
Sep 215.01 205.98 227.65 9.52
Oct 240.55 219.48 248.06 11.52
Nov 214.00 204.75 224.01 8.60
Dec 210.66 201.05 228.35 11.96

Krystal Biotech (KRYS) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 191.95 186.19 204.62 9.01
Feb 195.18 178.08 211.34 15.74
Mar 185.34 174.44 192.01 9.15
Apr 194.46 189.56 204.03 7.09
May 195.86 185.75 202.91 8.46
Jun 205.96 195.09 223.27 12.62
Jul 230.68 222.93 245.07 9.04
Aug 225.70 218.93 237.34 7.76
Sep 251.43 237.85 259.57 8.37
Oct 276.17 253.63 285.12 11.04
Nov 286.77 269.22 306.04 12.03
Dec 290.56 278.70 314.96 11.51

Krystal Biotech (KRYS) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 291.95 274.79 319.28 13.94
Feb 280.74 255.81 303.65 15.75
Mar 268.95 247.97 289.93 14.47
Apr 258.30 236.29 277.52 14.85
May 271.32 254.06 281.41 9.72
Jun 261.23 245.24 272.51 10.01
Jul 247.12 239.71 258.98 7.44
Aug 238.82 223.34 249.99 10.66
Sep 242.25 226.56 251.27 9.83
Oct 269.29 260.57 295.14 11.72
Nov 278.66 255.59 290.37 11.98
Dec 289.03 277.58 307.06 9.60

Krystal Biotech information and performance

Krystal Biotech Address

2100 WHARTON STREET, SUITE 701, PITTSBURGH, PA, US

Market Capitalization: 6 016 969 000 $

Market capitalization of the Krystal Biotech, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of KRYS shares in the company outstanding by the market price of one share.

EBITDA: -50 614 000 $

EBITDA of Krystal Biotech is earnings before interest, income tax and depreciation of assets.

PE Ratio: 95.33

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 2.21

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: 95.33

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 200

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 47.51

Enterprise Value (EV) /Revenue

EV To EBITDA: 75.54

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 28558400

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.